ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Impact of African-enriched GATM regulato…

Impact of African-enriched GATM regulatory variants on creatinine-derived estimated glomerular filtration rate

Kidney International·July 24Open Access
Urology & NephrologyPractice changingChronic Kidney DiseaseGlomerular Filtration Rate Estimation BiasGenome-Wide Association Study With Population-Based Cohort AnalysisBiomarkerAdultCreatinineCystatin CIohexol

Summary

View source

What was studied

This study examined whether African-enriched genetic variants at the GATM locus (encoding the rate-limiting enzyme in creatine biosynthesis) cause systematic bias in creatinine-based eGFR (eGFRCr) estimates, using whole-genome sequencing and phenotypic data from population-based cohorts in Uganda (n=5,760) and South Africa (n=827), with diagnostic validation in African American participants of the Million Veteran Program.

Key findings

African-enriched GATM variants (allele frequency ~50% in African populations, rare/absent in Europeans) were associated with ~2 ml/min/1.73 m² lower eGFRCr per allele, explained 1.0–1.7% of eGFRCr variance, and increased odds of a CKD diagnosis by eGFRCr thresholds — yet showed **no association** with measured GFR (iohexol) or cystatin C-based eGFR, confirming a biomarker-specific bias rather than true kidney dysfunction.

Study limitations

Study populations were limited to Uganda and South Africa for discovery, which may not represent all African-ancestry groups; the diagnostic analysis in African Americans relied on CKD diagnosis codes rather than directly measured GFR; and end-stage kidney disease was used as a hard outcome proxy, which may miss intermediate renal injury.

Clinical implications

In patients of African ancestry, eGFRCr may be systematically underestimated due to common GATM variants that raise serum creatinine without affecting true kidney function — consider cystatin C-based or measured GFR when CKD staging has major clinical implications in this population.

Related Questions

Explore related topics

How do GATM genetic variants affect creatinine levels in African ancestry patients with suspected CKD?When should cystatin C-based eGFR be preferred over creatinine-based eGFR in African American patients?What genetic factors explain racial disparities in CKD diagnosis and eGFR accuracy?

Publication Details

Year
2026
Journal
Kidney International
Sample Size
n=6,587
Source
View article
Keep scrolling
More content below.
Up Next